A Study of Lasmiditan in Healthy Participants When Co-administered With Topiramate
Clinical trial NCT03308669 · COMPLETED
Trial details
- NCT number
- NCT03308669
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2017-12-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.